ALLYL ISOCYANATE | CAS:1476-23-9

We serve ALLYL ISOCYANATE CAS:1476-23-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
ALLYL ISOCYANATE

Chemical Name:ALLYL ISOCYANATE
CAS.NO:1476-23-9
Synonyms:ALLYL ISOCYANATE
1-Propene, 3-isocyanato-
3-isocyanatoprop-1-ene
 
Physical and Chemical Properties:
Density 0.9±0.1 g/cm3
Boiling Point 88.0±0.0 °C at 760 mmHg
Molecular Formula C4H5NO
Molecular Weight 83.089
Flash Point 43.3±0.0 °C
 
Specification:
Appearance:Colourless to yellow liquid
Assay:≥99.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



Contact us for information like ALLYL ISOCYANATE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-isocyanatoprop-1-ene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,ALLYL ISOCYANATE Use and application,3-isocyanatoprop-1-ene technical grade,usp/ep/jp grade.


Related News: ICIG has agreed to offer employment to the unit’s approximately 120 employees upon closing, and plans to maintain operations at its primary location, a manufacturing facility in Liestal, Switzerland.4-Amino-3-nitrobenzotrifluoride manufacturer In 2016, in order to promote the innovative development, transformation and upgrading of the pharmaceutical industry, the Development and Reform Commission led the compilation of the “Guiding Opinions on Promoting the Healthy Development of the Pharmaceutical Industry”, which put forward requirements for all aspects of the medical industry and specifically proposed support for the field of chemical raw materials. .3-(Trifluoromethyl)pyridine-2-carboxylic acid supplier The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy.Ethyl 5-amino-1-(2-fluorobenzyl)-1H-pyrazole-3-carboxylate vendor “Ultimately, this is a public health decision,” she said, adding that the restrictions were precautionary measures to keep the country virus-free and contain the worldwide outbreak.Under the sub-licensing agreement, Mankind will market the drug under its own trademark while Glenmark will manufacture and supply it to the drug firm.